Global Blood: 3Q Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Global Blood Therapeutics Inc. (GBT) on Thursday reported a loss of $64.5 million in its third quarter.
The South San Francisco, California-based company said it had a loss of $1.07 per share.
The results missed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.03 per share.
Global Blood shares have climbed 15% since the beginning of the year. The stock has risen 13% in the last 12 months.